Sutter Hill Ventures
About UsTeamPortfolioNews
Networking & Computer Technology
Business & Financial Services
Healthcare
Software
Consumer
Investment Partnerships

Threshold Pharmaceuticals is a biotechnology company focused on the discovery and development of therapeutics based on Tumor Hypoxia, a powerful scientific platform that offers broad potential to treat most solid tumors. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional drugs.
.
.
Acceleron AkaRx Aksys
AmeriGroup Ameritox Amira
Amylin Pharmaceuticals Aspect Medical Systems Barrx
BRP - Blue Ridge Pharmaceutical Cardica Cor
Corcept Corixa Curis
Dionex Drais Horizon
Hybritech IBalance Idexx
Idun InfoMedics Interventional Technologies
Isis Pharmaceuticals Kalypto Medical Lifescan
Macusight Metronome Molecular Devices
Naryx Neurex NuGEN
Omnicell.com pacificbiosciences.com Portola Pharmaceutical
Pyxis Restoration Robotics Roxro Pharma
Threshold Pharmaceuticals Verinata Health Vical
Virobay Xoft microTube